CN108728399A - External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method - Google Patents
External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method Download PDFInfo
- Publication number
- CN108728399A CN108728399A CN201810311126.9A CN201810311126A CN108728399A CN 108728399 A CN108728399 A CN 108728399A CN 201810311126 A CN201810311126 A CN 201810311126A CN 108728399 A CN108728399 A CN 108728399A
- Authority
- CN
- China
- Prior art keywords
- small intestine
- centrifuge tube
- minutes
- organoid
- ice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000002220 organoid Anatomy 0.000 title claims abstract description 149
- 210000000813 small intestine Anatomy 0.000 title claims abstract description 116
- 238000000034 method Methods 0.000 title claims abstract description 31
- 238000007710 freezing Methods 0.000 title claims description 5
- 230000008014 freezing Effects 0.000 title claims description 5
- 230000000968 intestinal effect Effects 0.000 claims abstract description 113
- 238000005138 cryopreservation Methods 0.000 claims abstract description 22
- 238000011084 recovery Methods 0.000 claims abstract description 14
- 210000001198 duodenum Anatomy 0.000 claims abstract description 13
- 239000001963 growth medium Substances 0.000 claims abstract 3
- 239000000725 suspension Substances 0.000 claims description 52
- 239000006228 supernatant Substances 0.000 claims description 44
- 239000008055 phosphate buffer solution Substances 0.000 claims description 43
- 239000002131 composite material Substances 0.000 claims description 36
- 239000000243 solution Substances 0.000 claims description 36
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 31
- 239000011575 calcium Substances 0.000 claims description 31
- 239000007788 liquid Substances 0.000 claims description 29
- 239000002609 medium Substances 0.000 claims description 29
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 26
- 210000004027 cell Anatomy 0.000 claims description 18
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims description 17
- 229910001425 magnesium ion Inorganic materials 0.000 claims description 17
- 229910001424 calcium ion Inorganic materials 0.000 claims description 16
- 238000012546 transfer Methods 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 9
- 229930006000 Sucrose Natural products 0.000 claims description 9
- 239000005720 sucrose Substances 0.000 claims description 9
- 239000007853 buffer solution Substances 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical class OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 claims description 6
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 claims description 6
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 229930182555 Penicillin Natural products 0.000 claims description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 6
- 239000007640 basal medium Substances 0.000 claims description 6
- 235000011089 carbon dioxide Nutrition 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000010494 dissociation reaction Methods 0.000 claims description 6
- 230000005593 dissociations Effects 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 229940049954 penicillin Drugs 0.000 claims description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 108010016626 Dipeptides Proteins 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 210000000056 organ Anatomy 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 4
- 239000010452 phosphate Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000011740 C57BL/6 mouse Methods 0.000 claims description 3
- 102000009024 Epidermal Growth Factor Human genes 0.000 claims description 3
- 101800003838 Epidermal growth factor Proteins 0.000 claims description 3
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 3
- 239000000427 antigen Substances 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 230000000903 blocking effect Effects 0.000 claims description 3
- 210000004913 chyme Anatomy 0.000 claims description 3
- 229940116977 epidermal growth factor Drugs 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- CXKWCBBOMKCUKX-UHFFFAOYSA-M methylene blue Chemical compound [Cl-].C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 CXKWCBBOMKCUKX-UHFFFAOYSA-M 0.000 claims description 3
- 229960000907 methylthioninium chloride Drugs 0.000 claims description 3
- 210000002569 neuron Anatomy 0.000 claims description 3
- 239000011148 porous material Substances 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 238000003860 storage Methods 0.000 claims description 3
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 3
- 239000012498 ultrapure water Substances 0.000 claims description 3
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 2
- 108091016585 CD44 antigen Proteins 0.000 claims description 2
- 102000008186 Collagen Human genes 0.000 claims description 2
- 108010035532 Collagen Proteins 0.000 claims description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 claims description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 claims description 2
- 102000008055 Heparan Sulfate Proteoglycans Human genes 0.000 claims description 2
- 229920002971 Heparan sulfate Polymers 0.000 claims description 2
- 101001059454 Homo sapiens Serine/threonine-protein kinase MARK2 Proteins 0.000 claims description 2
- 108010088225 Nestin Proteins 0.000 claims description 2
- 102000008730 Nestin Human genes 0.000 claims description 2
- 102100028904 Serine/threonine-protein kinase MARK2 Human genes 0.000 claims description 2
- 108090000054 Syndecan-2 Proteins 0.000 claims description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 2
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 2
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 2
- 229920001436 collagen Polymers 0.000 claims description 2
- 229940126864 fibroblast growth factor Drugs 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 210000005055 nestin Anatomy 0.000 claims description 2
- 102000045246 noggin Human genes 0.000 claims description 2
- 108700007229 noggin Proteins 0.000 claims description 2
- 229920002866 paraformaldehyde Polymers 0.000 claims description 2
- -1 streptomysin Proteins 0.000 claims description 2
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 20
- 238000001556 precipitation Methods 0.000 claims 5
- 238000006116 polymerization reaction Methods 0.000 claims 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- 108010044940 alanylglutamine Proteins 0.000 claims 2
- 238000005119 centrifugation Methods 0.000 claims 2
- 230000001143 conditioned effect Effects 0.000 claims 2
- 235000015110 jellies Nutrition 0.000 claims 2
- 239000008274 jelly Substances 0.000 claims 2
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 102000013275 Somatomedins Human genes 0.000 claims 1
- 238000013019 agitation Methods 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 238000004113 cell culture Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 229960001484 edetic acid Drugs 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 239000000284 extract Substances 0.000 claims 1
- 239000012894 fetal calf serum Substances 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 238000009938 salting Methods 0.000 claims 1
- 230000003068 static effect Effects 0.000 claims 1
- 238000004659 sterilization and disinfection Methods 0.000 claims 1
- 239000011550 stock solution Substances 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 abstract description 26
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 15
- 210000001630 jejunum Anatomy 0.000 abstract description 10
- 210000003405 ileum Anatomy 0.000 abstract description 9
- 241000699670 Mus sp. Species 0.000 abstract description 8
- 238000000605 extraction Methods 0.000 abstract description 3
- 238000012258 culturing Methods 0.000 abstract 1
- 238000003125 immunofluorescent labeling Methods 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
- 239000002771 cell marker Substances 0.000 description 24
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 16
- 229910052749 magnesium Inorganic materials 0.000 description 16
- 239000011777 magnesium Substances 0.000 description 16
- 229910052791 calcium Inorganic materials 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 10
- 238000010166 immunofluorescence Methods 0.000 description 9
- 102000010792 Chromogranin A Human genes 0.000 description 8
- 108010038447 Chromogranin A Proteins 0.000 description 8
- 108010088406 Glucagon-Like Peptides Proteins 0.000 description 8
- 102000016943 Muramidase Human genes 0.000 description 8
- 108010014251 Muramidase Proteins 0.000 description 8
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 8
- 108090000195 villin Proteins 0.000 description 8
- 102000000905 Cadherin Human genes 0.000 description 7
- 108050007957 Cadherin Proteins 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 230000002183 duodenal effect Effects 0.000 description 5
- 210000003890 endocrine cell Anatomy 0.000 description 5
- 210000002175 goblet cell Anatomy 0.000 description 5
- 210000003134 paneth cell Anatomy 0.000 description 5
- 239000008188 pellet Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000007296 Mucin-2 Human genes 0.000 description 4
- 108010008705 Mucin-2 Proteins 0.000 description 4
- 102000015728 Mucins Human genes 0.000 description 4
- 108010063954 Mucins Proteins 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000004325 lysozyme Substances 0.000 description 4
- 229960000274 lysozyme Drugs 0.000 description 4
- 235000010335 lysozyme Nutrition 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 210000002919 epithelial cell Anatomy 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- FPNZBYLXNYPRLR-UHFFFAOYSA-N 2-(4-carbamimidoylphenyl)-1h-indole-6-carboximidamide;hydron;dichloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FPNZBYLXNYPRLR-UHFFFAOYSA-N 0.000 description 2
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 229960002648 alanylglutamine Drugs 0.000 description 2
- 210000004534 cecum Anatomy 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 239000006059 cover glass Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000000713 mesentery Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015816 nutrient absorption Nutrition 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 210000001187 pylorus Anatomy 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102100030511 Stanniocalcin-1 Human genes 0.000 description 1
- 101710142157 Stanniocalcin-1 Proteins 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 210000003892 absorptive cell Anatomy 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000012592 cell culture supplement Substances 0.000 description 1
- 230000036755 cellular response Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018514 detection of nutrient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000005081 epithelial layer Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 125000000404 glutamine group Chemical group N[C@@H](CCC(N)=O)C(=O)* 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021238 nutrient digestion Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0679—Cells of the gastro-intestinal tract
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0062—General methods for three-dimensional culture
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases [EC 2.]
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/73—Hydrolases (EC 3.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/999—Small molecules not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/70—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Environmental Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Dentistry (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明公开了一种基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏和鉴定方法。该方法包括:(1)对小鼠十二指肠、空肠和回肠区段的隐窝进行分离;(2)对小鼠十二指肠、空肠和回肠区段的隐窝进行3D培养,形成类器官;(3)小鼠小肠类器官传代;(4)小鼠小肠类器官冻存;(5)小鼠小肠类器官复苏;(6)小鼠小肠类器官冰冻切片制备;(7)小鼠小肠类器官冰冻切片免疫荧光标记及鉴定。相比于现有技术,本发明以含有干细胞的小肠隐窝为基础,优化了隐窝提取方式、体外培养体系和培养基,并包含完整的培养、传代、冻存、复苏和鉴定方法。此方法获得小肠类器官可以反复传代,且传代类器官具有性状稳定性。
The invention discloses a method for in vitro organoid 3D culture, subculture, cryopreservation, recovery and identification based on different sections of the small intestine of mice. The method includes: (1) isolating the crypts of the mouse duodenum, jejunum and ileum; (2) 3D culturing the crypts of the mouse duodenum, jejunum and ileum to form Organoids; (3) passage of mouse small intestine organoids; (4) cryopreservation of mouse small intestine organoids; (5) recovery of mouse small intestine organoids; (6) preparation of frozen sections of mouse small intestine organoids; Immunofluorescent labeling and identification of frozen sections of mouse intestinal organoids. Compared with the prior art, the present invention is based on small intestinal crypts containing stem cells, optimizes the crypt extraction method, in vitro culture system and culture medium, and includes complete methods of culture, subculture, cryopreservation, recovery and identification. The small intestine organoids obtained by this method can be repeatedly passaged, and the passaged organoids have stable properties.
Description
技术领域technical field
本发明涉及一种基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏和鉴定方法。The invention relates to a method for in vitro organoid 3D culture, passage, cryopreservation, recovery and identification based on different sections of the small intestine of mice.
背景技术Background technique
小肠作为人体最大的营养物质消化和吸收器官,由于其在代谢紊乱疾病如肥胖及糖尿病的重要作用,人们对肠道营养物质吸收、转运、感受和激素释放的兴趣日益增长。目前用于小肠营养物感受、转运、吸收及局部激素调节功能研究的体外模型主要分为两类:一类是以肠道组织为基础的模型,包括环法、外翻肠囊、尤斯灌流室和离体肠灌注,上述模型可以用于正常生理条件下微生物、上皮细胞、免疫细胞、神经细胞及其他细胞在组织中的相互作用;一类是以肿瘤细胞系为基础的模型,包括各种转化的肠道上皮细胞系,如Caco-2,HT29,NCI-H716,STC-1等,上述Caco-2细胞模型结合跨膜分析技术(Transwell)可以产生极化上皮层,用于体外上皮细胞反应研究。The small intestine is the largest nutrient digestion and absorption organ in the human body. Due to its important role in metabolic disorders such as obesity and diabetes, there is growing interest in intestinal nutrient absorption, transport, perception, and hormone release. Currently, the in vitro models used for the study of nutrient sensing, transport, absorption and local hormone regulation in the small intestine are mainly divided into two categories: one is based on intestinal tissue, including ring method, everted intestinal sac, and Uss perfusion. Chamber and isolated intestinal perfusion, the above models can be used for the interaction of microorganisms, epithelial cells, immune cells, nerve cells and other cells in tissues under normal physiological conditions; one type is based on tumor cell lines, including various A transformed intestinal epithelial cell line, such as Caco-2, HT29, NCI-H716, STC-1, etc., the above Caco-2 cell model combined with transmembrane analysis technology (Transwell) can produce polarized epithelial layers for in vitro epithelial Cell Response Studies.
但是,上述肠道功能体外研究模型均存在一定缺陷:肠道组织基础上的模型,因为上述模型需要获取离体组织,实验对象数量有限情况下将无法获得足够质量及数量的组织,而且离体组织具有时间有效性,因此只有有限的功能测试时间,实验的重复性及稳定性差。同时为了获取足够数据,动物使用量高。细胞基础上的模型,细胞组成单一,无法真正再现肠道细胞与细胞之间,细胞与细胞基质之间的相互作用。However, the above-mentioned in vitro research models of intestinal function have certain defects: the models based on intestinal tissue, because the above-mentioned models need to obtain isolated tissues, and it is impossible to obtain sufficient quality and quantity of tissues when the number of experimental subjects is limited, and the in vitro The organization is time-effective, so there is only a limited time for functional testing, and the repeatability and stability of the experiment are poor. At the same time, in order to obtain sufficient data, the number of animals used is high. The cell-based model has a single cell composition and cannot truly reproduce the interaction between intestinal cells and between cells and the cell matrix.
发明内容Contents of the invention
有鉴于此,本发明的目的在于提供一种基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏和鉴定方法。该方法区别于现有技术,优化了隐窝提取方式、体外培养体系和培养基,并包含了完整的培养、传代、冻存、复苏和鉴定等方法。进一步地,此培养方法获得小肠类器官可以反复传代,且传代类器官具有性状稳定性。In view of this, the purpose of the present invention is to provide a method for 3D culture, passage, cryopreservation, recovery and identification of in vitro organoids based on different sections of the small intestine of mice. This method is different from the prior art in that it optimizes the crypt extraction method, in vitro culture system and medium, and includes complete methods of culture, subculture, cryopreservation, recovery and identification. Furthermore, the small intestinal organoids obtained by this culture method can be repeatedly passaged, and the passaged organoids have stable properties.
为实现上述目的,本发明提供如下技术方案:To achieve the above object, the present invention provides the following technical solutions:
一种基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏方法,包括以下几个步骤:A method for in vitro organoid 3D culture, passage, cryopreservation, and recovery based on different segments of the small intestine of mice, comprising the following steps:
步骤一、收集一只8-10周大的雄性C57BL/6小鼠的小肠,放入预冷的无钙、镁离子磷酸盐缓冲溶液中,置于冰上;用眼科镊清除小肠残留肠系膜,将小肠从十二指肠段沿纵轴纵向剖开,用预冷的无钙、镁离子磷酸盐缓冲溶液清洗去除肠道中的食糜,得到清洗干净的小肠;将清洗完毕的小肠分成三等分,分别剪取前端靠近胃部的4厘米小肠作为十二指肠段,中间段小肠的中间部4厘米为空肠段,后端靠近回盲肠部的4厘米为回肠段;将三段小肠部位用无水乙醇中浸泡5分钟后,用消毒盖玻片沿小肠绒毛面轻轻刮三段小肠部位2-3次;用预冷的无钙、镁离子磷酸盐缓冲溶液清洗三段小肠;用眼科剪将三段小肠沿纵轴剪成3-5毫米的小段,将十二指肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管1中清洗,将空肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管2中清洗,将回肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管3中清洗,清洗时分别将离心管1、2和3轻轻来回颠倒10-15次;清洗完毕后,将离心管1、2和3分别置于冰上使小肠碎片自然沉降于离心管1、2和3底部,然后去除上清液;分别在离心管1和2中加入8毫升预冷的浓度为2mM,pH为8.0的乙二胺四乙酸溶液后,横向埋于冰盒中用回旋式摇床以40-50rpm的速度振荡30分钟进行消化;在离心管3中加入8毫升预冷的浓度为5mM,pH为8.0的乙二胺四乙酸溶液后,横向埋于冰盒中用回旋式摇床以40-50rpm的速度振荡45分钟进行消化;将离心管1、2和3分别置于冰上自然沉降,去除上清液;向离心管1、2和3中分别加入预冷的无钙、镁离子磷酸盐缓冲溶液后,将离心管1、2和3分别上下颠倒10-15次进行清洗;Step 1. Collect the small intestine of an 8-10-week-old male C57BL/6 mouse, put it into a pre-cooled calcium- and magnesium-free phosphate buffer solution, and place it on ice; remove the residual mesentery of the small intestine with ophthalmic forceps, Cut the small intestine longitudinally along the longitudinal axis from the duodenum, wash with pre-cooled calcium and magnesium ion-free phosphate buffer solution to remove the chyme in the intestine, and obtain the cleaned small intestine; divide the cleaned small intestine into three equal parts The 4 cm small intestine at the front end close to the stomach was cut as the duodenum segment, the 4 cm middle part of the middle small intestine was the jejunum segment, and the 4 cm rear end close to the ileocecum was the ileum segment; the three small intestine parts were After immersing in absolute ethanol for 5 minutes, use a sterile cover glass to gently scrape the three sections of the small intestine 2-3 times along the villi of the small intestine; wash the three sections of the small intestine with pre-cooled calcium- and magnesium-ion-free phosphate buffer solution; Ophthalmic scissors: Cut the three sections of small intestine into 3-5 mm small sections along the longitudinal axis, wash the duodenum section in centrifuge tube 1 containing 8 ml of pre-cooled phosphate buffer solution without calcium and magnesium ions, and clean the jejunum Place the segment in centrifuge tube 2 containing 8 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution for washing, and place the ileum segment in centrifuge tube 3 containing 8 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution To clean, gently invert the centrifuge tubes 1, 2 and 3 back and forth 10-15 times; after cleaning, place the centrifuge tubes 1, 2 and 3 on ice to allow the small intestine fragments to settle naturally in the centrifuge tubes 1 and 2 and 3 bottoms, and then remove the supernatant; add 8 ml of pre-cooled EDTA solution with a concentration of 2 mM and a pH of 8.0 to centrifuge tubes 1 and 2 respectively, bury them horizontally in an ice box, and shake The bed was shaken at a speed of 40-50rpm for 30 minutes for digestion; after adding 8 ml of pre-cooled EDTA solution with a concentration of 5mM and a pH of 8.0 to the centrifuge tube 3, bury it horizontally in an ice box and shake it with a rotary The bed was shaken at a speed of 40-50rpm for 45 minutes for digestion; the centrifuge tubes 1, 2 and 3 were placed on ice to settle naturally, and the supernatant was removed; the pre-cooled calcium-free , Magnesium ion phosphate buffer solution, wash centrifuge tubes 1, 2 and 3 upside down for 10-15 times respectively;
步骤二,将步骤一中清洗完成的离心管1、2和3置于冰上自然沉降,去除上清液后,分别加入7.5毫升预冷的无钙、镁离子磷酸盐缓冲溶液,轻柔振荡50次,脱出小肠碎片中的隐窝,随后将离心管1、2和3置于冰上自然沉降后,将离心管1、2和3上清液合并收集至50毫升离心管4中;采用100微米孔径的细胞筛对离心管4中的上清液进行过滤,滤液转移至50毫升离心管5中;重复多次,直至每100微升离心管4中的收集液中少于10个隐窝时,停止收集;Step 2: Place the centrifuge tubes 1, 2 and 3 cleaned in step 1 on ice to settle naturally. After removing the supernatant, add 7.5 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and shake gently for 50 The second time, the crypts in the small intestine fragments were removed, and then centrifuge tubes 1, 2 and 3 were placed on ice to settle naturally, and the supernatants of centrifuge tubes 1, 2 and 3 were combined and collected into 50 ml centrifuge tube 4; using 100 Filter the supernatant in the centrifuge tube 4 with a cell sieve with a micron pore size, and transfer the filtrate to the 50 ml centrifuge tube 5; repeat several times until there are less than 10 crypts in the collected liquid in the centrifuge tube 4 per 100 microliters , stop collecting;
步骤三、将步骤二中得到的含有隐窝的离心管5以150g转速和4℃温度下离心10分钟;去除离心管5中的上清液,加入3毫升预冷的无钙、镁离子磷酸盐缓冲溶液后,得隐窝悬液,移液枪吸取20微升隐窝悬液,滴于载玻片上,倒置显微镜下计数隐窝数量;将隐窝悬液转移到15毫升离心管6中以150g转速和4℃温度下离心10分钟,去除离心管6中的上清液,得隐窝沉淀,并将隐窝沉淀置于冰上;Step 3, centrifuge the centrifuge tube 5 containing crypts obtained in step 2 at a speed of 150g and a temperature of 4°C for 10 minutes; remove the supernatant in the centrifuge tube 5, and add 3 ml of precooled calcium- and magnesium-ion-free phosphoric acid After the salt buffer solution, get the crypt suspension, pipette 20 microliters of the crypt suspension, drop it on the glass slide, count the number of crypts under an inverted microscope; transfer the crypt suspension to a 15ml centrifuge tube 6 Centrifuge at 150g and 4°C for 10 minutes, remove the supernatant in centrifuge tube 6 to obtain crypt pellets, and place the crypt pellets on ice;
步骤四、向步骤三中得到的隐窝沉淀中按照每孔50微升的剂量加入相应体积的冰上预融化的复合凝胶液,用预冷移液枪头在冰上轻轻吹打形成均匀小肠隐窝复合凝胶悬液1;将小肠隐窝复合凝胶悬液1按照每孔50微升体积接种于37℃预热的24孔培养板1中;将24孔培养板1置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板1的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到初代小肠类器官;Step 4: Add a corresponding volume of pre-thawed composite gel solution on ice to the crypt pellet obtained in Step 3 at a dose of 50 microliters per well, and gently blow on ice with a pre-cooled pipette tip to form a uniform gel. Small intestinal crypt complex gel suspension 1; inoculate the small intestinal crypt complex gel suspension 1 in a 24-well culture plate 1 preheated at 37°C in a volume of 50 microliters per well; place the 24-well culture plate 1 at temperature In a carbon dioxide incubator at 37°C for 30 minutes; after the composite gel is completely polymerized, add 500 microliters of complete medium to each well of 24-well culture plate 1, and replace the complete medium every 3 days to obtain the primary small intestine organoids;
步骤五、在步骤四接种后6天,去除步骤四中24孔培养板中培养基,然后在每孔中加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液2;用注射器吸取全部复合凝胶悬液2后推出,重复一次,使隐窝类似结构从小肠类器官中释放,得到解离小肠类器官悬液1;将解离小肠类器官悬液1转移至15毫升离心管7中,以200g转速和4℃温度下离心10分钟,去除离心管7中上清液;向含有解离小肠类器官悬液1的离心管7中加入150-250微升冰上预融化的复合凝胶液,用移液枪吹打3-4次制成冰上预融化的复合凝胶悬液3;将复合凝胶悬液3按照每孔50微升体积接种于37℃预热24孔培养板2中;将24孔培养板2置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板2的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到传代小肠类器官;Step five, 6 days after inoculation in step four, remove the medium in the 24-well culture plate in step four, then add 500 microliters of pre-cooled calcium and magnesium ion-free phosphate buffered saline buffer solution to each well and place it on ice, Use a pipette gun to repeatedly blow the composite gel in each well until it breaks to obtain a composite gel suspension 2; absorb the entire composite gel suspension 2 with a syringe and push it out, repeat once to make the crypt similar to the structure of the small intestine organoid Release to obtain dissociated small intestinal organoid suspension 1; transfer the dissociated small intestinal organoid suspension 1 to a 15ml centrifuge tube 7, centrifuge at 200g and 4°C for 10 minutes, and remove the supernatant in centrifuge tube 7 ; Add 150-250 microliters of pre-thawed composite gel solution on ice to the centrifuge tube 7 containing the dissociated small intestinal organoid suspension 1, and blow it 3-4 times with a pipette gun to make a pre-thawed composite gel solution on ice. Gel suspension 3; inoculate the composite gel suspension 3 in a preheated 24-well culture plate 2 at 37°C at a volume of 50 microliters per well; place the 24-well culture plate 2 in a carbon dioxide incubator at a temperature of 37°C for 30 Minutes; after the composite gel is completely polymerized, add 500 microliters of complete medium to each well of 24-well culture plate 2, and replace the complete medium every 3 days to obtain passaged small intestinal organoids;
步骤六、在步骤五小肠类器官传代3天后,将24孔培养板2中的传代小肠类器官去除培养基后,加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液3;将复合凝胶悬液3转移至15毫升离心管8中,以200g转速和4℃温度下离心10分钟,去除离心管8中上清液;在离心管8中加入1毫升冻存液后,得小肠类器官重悬液;以2-3孔小肠类器官重悬液为一组,转移至一根2毫升冻存管中,放于含异丙醇的冻存盒中,-80℃放置24小时后放入液氮中长期保存,得到冻存小肠类器官;Step 6. After 3 days of passage of small intestine organoids in step 5, remove the medium from the passage small intestine organoids in 24-well culture plate 2, add 500 microliters of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and place on ice above, use a pipette gun to repeatedly blow the composite gel in each well until it breaks to obtain a composite gel suspension 3; Centrifuge for 10 minutes, remove the supernatant in centrifuge tube 8; add 1 ml of cryopreservation solution to centrifuge tube 8 to obtain small intestinal organoid resuspension; use 2-3 wells of small intestinal organoid resuspension as a group, transfer Put it into a 2ml cryopreservation tube, put it in a cryopreservation box containing isopropanol, store it at -80°C for 24 hours, and then put it in liquid nitrogen for long-term storage to obtain cryopreserved small intestinal organoids;
步骤七、将存有小肠类器官重悬液的冻存管从液氮中取出,立即放入37℃水浴锅中速溶,待小肠类器官重悬液完全融化后,转移小肠类器官重悬液到15毫升离心管9中,加入预冷基础培养基至5毫升,在转速200g条件下离心10分钟;去除离心管9的上清液后,加入100微升复合凝胶液,得到小肠类器官复苏重悬液;将小肠类器官复苏重悬液按照每孔50微升体积接种于37℃预热24孔培养板3中;将24孔培养板3置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板3的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到复苏小肠类器官。Step 7. Take out the cryopreservation tube containing the small intestinal organoid resuspension from the liquid nitrogen, and immediately put it in a 37°C water bath for instant dissolution. After the small intestinal organoid resuspension is completely melted, transfer the small intestinal organoid resuspension Add pre-cooled basal medium to 5 ml into 15 ml centrifuge tube 9, centrifuge at 200 g for 10 minutes; remove the supernatant of centrifuge tube 9, add 100 microliters of composite gel solution to obtain small intestinal organoids Resuscitation resuspension; inoculate small intestinal organoid resuspension in a volume of 50 microliters per well in preheated 24-well culture plate 3 at 37°C; place 24-well culture plate 3 in a carbon dioxide incubator at 37°C 30 minutes; after the composite gel was completely polymerized, 500 microliters of complete medium was added to each well of 24-well culture plate 3, and the complete medium was replaced every 3 days to obtain a revived small intestinal organoid.
进一步地,步骤四、五和七中所述复合凝胶液提取自小鼠肉瘤,由粘连蛋白、胶原蛋白IV、巢蛋白、硫酸乙酰肝素蛋白多糖、转化生长因子-β、表皮生长因子、类胰岛素生长因子、成纤维细胞生长因子和组织纤溶酶原激活剂组成。Further, the composite gel liquid described in steps 4, 5 and 7 is extracted from mouse sarcoma, and is composed of laminin, collagen IV, nestin, heparan sulfate proteoglycan, transforming growth factor-β, epidermal growth factor, Composition of insulin growth factor, fibroblast growth factor and tissue plasminogen activator.
步骤四、五和七中所述完全培养基由R-spondin条件培养基、Noggin条件培养基、DMEM/F12培养基、4-羟乙基哌嗪乙磺酸、L-丙氨酰-L-谷氨酰胺二肽、青霉素、链霉素、表皮生长因子、神经元细胞培养补充剂N2和B27、Rho相关形成蛋白丝氨酸/苏氨酸激酶卷曲螺旋抑制剂Y27632组成。The complete medium described in steps four, five and seven consists of R-spondin conditioned medium, Noggin conditioned medium, DMEM/F12 medium, 4-hydroxyethylpiperazineethanesulfonic acid, L-alanyl-L- Composition of glutamine dipeptide, penicillin, streptomycin, epidermal growth factor, neuronal cell culture supplements N2 and B27, Rho-associated forming protein serine/threonine kinase coiled-coil inhibitor Y27632.
步骤七中所述基础培养基由DMEM/F12培养基、4-羟乙基哌嗪乙磺酸、L-丙氨酰-L-谷氨酰胺二肽、青霉素和链霉素组成。The basal medium described in step seven consists of DMEM/F12 medium, 4-hydroxyethylpiperazineethanesulfonic acid, L-alanyl-L-glutamine dipeptide, penicillin and streptomycin.
步骤六中所述冻存液由DMEM/F12培养基、4-羟乙基哌嗪乙磺酸、L-丙氨酰-L-谷氨酰胺二肽、青霉素、链霉素、胎牛血清和二甲基亚砜组成。The cryopreservation solution described in step 6 consists of DMEM/F12 medium, 4-hydroxyethylpiperazineethanesulfonic acid, L-alanyl-L-glutamine dipeptide, penicillin, streptomycin, fetal bovine serum and Composed of dimethyl sulfoxide.
本发明还提供了基于小鼠不同区段小肠的体外类器官鉴定方法,包括以下几个步骤:The present invention also provides an in vitro organoid identification method based on different sections of the small intestine of mice, which includes the following steps:
步骤一、选择初代、传代和复苏小肠类器官中的任一小肠类器官作为鉴定对象,培养6天后去除培养基,加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液4;将复合凝胶悬液4转移至15毫升离心管10中,在转速200g条件下离心10分钟;去除离心管9的上清液后,加入提前冰上预冷的溶度为4%的多聚甲醛,在温度20-25℃条件下固定15分钟;固定完毕后,将离心管10中在转速200g条件下离心10分钟,去除上清液;在离心管10中加入无钙、镁离子磷酸盐缓冲溶液,在转速200g条件下离心5分钟后去除上清液,重复3次;随后向离心管10中的沉淀中加入2毫升溶度为0.01%的亚甲基蓝溶液,在温度20-25℃条件下孵育20分钟;孵育完成后,将离心管10在转速200g条件下离心10分钟,去除上清液;在离心管10中加入无钙、镁离子磷酸盐缓冲溶液,在转速200g条件下离心5分钟后去除上清液,重复3次;随后向离心管10中的沉淀中加入1毫升溶度为20%的蔗糖溶液,在温度4℃条件下过夜放置12小时,得到含有小肠类器官蔗糖溶液的离心管10;Step 1. Select any small intestinal organoid among primary, subcultured and resuscitated small intestinal organoids as the identification object, remove the medium after 6 days of culture, add 500 microliters of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and place on ice above, use a pipette gun to repeatedly blow the composite gel in each well until it breaks to obtain a composite gel suspension 4; transfer the composite gel suspension 4 to a 15 ml centrifuge tube 10, and centrifuge at a speed of 200g for 10 minutes ; After removing the supernatant of the centrifuge tube 9, add paraformaldehyde with a solubility of 4% pre-cooled on ice in advance, and fix it at a temperature of 20-25° C. for 15 minutes; Centrifuge at a speed of 200g for 10 minutes to remove the supernatant; add calcium and magnesium ion-free phosphate buffer solution to the centrifuge tube 10, remove the supernatant after centrifuging at a speed of 200g for 5 minutes, and repeat 3 times; Add 2 ml of methylene blue solution with a solubility of 0.01% to the precipitate in tube 10, and incubate at a temperature of 20-25°C for 20 minutes; after the incubation is completed, centrifuge the centrifuge tube 10 at a speed of 200g for 10 minutes, and remove the supernatant solution; in the centrifuge tube 10, add calcium-free and magnesium ion-free phosphate buffer solution, remove the supernatant after centrifuging at a speed of 200g for 5 minutes, and repeat 3 times; 20% sucrose solution, placed overnight at 4°C for 12 hours to obtain a centrifuge tube 10 containing the small intestine organoid sucrose solution;
步骤二、将离心管10中的小肠类器官蔗糖溶液转移至1.5毫升离心管11中,在转速4000rpm条件下离心30-60秒后加入50-100微升冰冻切片包埋剂,轻轻悬浮后,在温度20-25℃条件下静止20-30分钟;待小肠类器官沉降于1.5毫升离心管11后,将离心管11置于干冰上速冻1-3分钟;将成块小肠类器官从离心管11中取出,含小肠类器官的那一面向下,置于含冰冻切片包埋剂的包埋盒中二次包埋,用干冰速冻1-3分钟,得到小肠类器官包埋物;速冻完成后,采用冰冻切片机对小肠类器官包埋物以8-10微米的厚度进行切片,得小肠类器官包埋切片1;将小肠类器官包埋切片1置于烘片机上,在42℃温度下烘30分钟后,制得烘干后的小肠类器官包埋切片2,将小肠类器官包埋切片2放入切片盒中,在-80℃冰箱中保存备用;Step 2. Transfer the small intestinal organoid sucrose solution in centrifuge tube 10 to 1.5 ml centrifuge tube 11, centrifuge at 4000 rpm for 30-60 seconds, add 50-100 microliters of cryosection embedding agent, and gently suspend , stand still at a temperature of 20-25°C for 20-30 minutes; after the small intestinal organoids have settled in the 1.5 ml centrifuge tube 11, place the centrifuge tube 11 on dry ice for 1-3 minutes; remove the block of small intestinal organoids from the centrifuge tube Take it out in 11, place the side containing the small intestinal organoid downward, place it in the embedding box containing the frozen section embedding agent for secondary embedding, and freeze it with dry ice for 1-3 minutes to obtain the small intestinal organoid embedding; the quick freezing is completed Finally, slice the small intestinal organoid embedding material with a thickness of 8-10 microns using a frozen microtome to obtain the small intestinal organoid embedding slice 1; place the small intestinal organoid embedding slice 1 on a drying machine, and heat After drying for 30 minutes, the dried small intestinal organoid-embedded slice 2 was prepared, and the small intestinal organoid-embedded slice 2 was put into a slice box, and stored in a -80°C refrigerator for later use;
步骤三、将步骤二中得到的小肠类器官包埋切片2从-80℃冰箱取出,置于烘片机上,在42℃温度下烘20分钟;随后,将小肠类器官包埋切片2放于孵育盒中,用磷酸盐缓冲溶液清洗10分钟;随后,去除磷酸盐缓冲溶液,加入抗原封闭液,温度20-25℃条件下孵育30-45分钟,得小肠类器官包埋切片3;在小肠类器官包埋切片3中加入一抗,在温度4℃条件下过夜放置12小时,得小肠类器官包埋切片4;Step 3. Take the small intestinal organoid-embedded slice 2 obtained in step 2 out of the -80°C refrigerator, place it on a drying machine, and bake it at 42°C for 20 minutes; then, place the small intestinal organoid-embedded slice 2 on In the incubation box, wash with phosphate buffer solution for 10 minutes; then, remove the phosphate buffer solution, add antigen blocking solution, and incubate at a temperature of 20-25°C for 30-45 minutes to obtain small intestinal organoid embedded slice 3; Add the primary antibody to the organoid-embedded slice 3, and place it overnight at 4°C for 12 hours to obtain the small intestine organoid-embedded slice 4;
步骤四、将步骤三中得到的小肠类器官包埋切片4用磷酸盐缓冲溶液重复清洗3次,每次5分钟,得小肠类器官包埋切片5;在小肠类器官包埋切片5中加入与步骤三中一抗相对应的二抗,温度20-25℃条件下孵育30分钟,得小肠类器官包埋切片6;将小肠类器官包埋切片6用磷酸盐缓冲溶液重复清洗4次,每次5分钟;随后,加入2-(4-脒基苯基)-6-吲哚脒二盐酸盐溶液,温度20-25℃条件下孵育5分钟;用超纯水以清洗1-2次,每次5分钟,得小肠类器官包埋切片7;最后用封片剂对小肠类器官包埋切片7进行封片,得到小肠类器官封片;Step 4. Wash the small intestinal organoid-embedded slice 4 obtained in step 3 repeatedly with phosphate buffer solution for 3 times, each time for 5 minutes, to obtain the small intestinal organoid-embedded slice 5; add the small intestinal organoid embedded slice 5 to The secondary antibody corresponding to the primary antibody in step 3 was incubated at 20-25°C for 30 minutes to obtain the small intestinal organoid-embedded slice 6; the small intestinal organoid-embedded slice 6 was repeatedly washed 4 times with phosphate buffered saline, 5 minutes each time; then, add 2-(4-amidinophenyl)-6-indoleamidine dihydrochloride solution and incubate at 20-25°C for 5 minutes; wash with ultrapure water for 1-2 times, 5 minutes each time, to obtain the small intestinal organoid-embedded slice 7; finally, seal the small intestinal organoid-embedded slice 7 with a mounting agent to obtain the small intestinal organoid-embedded slice;
步骤五,采用激光共聚焦显微镜对步骤四中得到的小肠类器官封片进行观察,获取免疫荧光图像及鉴定。Step 5: Using a laser confocal microscope to observe the mounted small intestinal organoids obtained in Step 4 to obtain immunofluorescence images and identify them.
本发明具有以下优点及有益效果:The present invention has the following advantages and beneficial effects:
相比于现有的技术方法,本发明提供的方法具有以下几个显著的优点和进步:Compared with prior art methods, the method provided by the invention has the following significant advantages and progress:
1、本发明的技术方法,优化了小鼠小肠不同位段的选取位置,对提取流程进行了优化,能够保证小肠类器官体外培养顺利完成。1. The technical method of the present invention optimizes the selection positions of different segments of the mouse small intestine, optimizes the extraction process, and can ensure the smooth completion of small intestinal organoid culture in vitro.
2、本发明的技术方法,对小鼠小肠类器官体外培养体系采用的培养体系、复合凝胶液、完全培养基和基础培养基等培养关键性生化试剂进行了突破性优化,进而保证小肠类器官能够在体外实现正常培养、反复传代、冻存和反复复苏,且具有传代稳定性。2. The technical method of the present invention has carried out a breakthrough optimization of key biochemical reagents such as the culture system, composite gel solution, complete medium and basal medium used in the in vitro culture system of mouse small intestinal organoids, thereby ensuring that the small intestinal organoids Organs can achieve normal culture, repeated passage, cryopreservation and repeated resuscitation in vitro, and have passage stability.
3、本发明的技术方法,除了提供完整的体外培养方法,还提供了完整的体外传代、冻存和复苏方法,保证了小肠类器官在体外的循环使用性。3. The technical method of the present invention, in addition to providing a complete in vitro culture method, also provides a complete in vitro passage, cryopreservation and recovery method, which ensures the recycling of small intestinal organoids in vitro.
4、本发明的技术方法,优化了小肠类器官的体外鉴定方法,能够明确小肠类器官的可靠性。4. The technical method of the present invention optimizes the in vitro identification method of small intestinal organoids, and can clarify the reliability of small intestinal organoids.
附图说明Description of drawings
图1是小肠分段收集示意图。Figure 1 is a schematic diagram of collection of small intestine segments.
图2是小肠类器官的体外培养生长图。Figure 2 is a diagram of the in vitro culture growth of small intestinal organoids.
图3是小肠类器官的体外传代12次培养生长图。Fig. 3 is a graph showing the growth of small intestinal organoids cultured in vitro for 12 passages.
图4是小肠类器官的免疫荧光鉴定图。Figure 4 is an immunofluorescence identification diagram of small intestinal organoids.
具体实施例specific embodiment
本发明公开了一种基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏和鉴定方法,本领域技术人员可以借鉴本文内容,适当改进参数实现。特别需要指出的是,所有类似的替换和改动对本领域技术人员来说是显而易见的,它们都被视为包括在本发明。本发明所述方法已经通过较佳实施例进行了描述,相关人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和应用进行改动或适当变更与组合,来实现和应用本发明。The present invention discloses a method for 3D culture, subculture, cryopreservation, recovery and identification of in vitro organoids based on different sections of the small intestine of mice. Those skilled in the art can learn from the content of this article and appropriately improve the parameters to realize it. In particular, it should be pointed out that all similar replacements and modifications are obvious to those skilled in the art, and they are all considered to be included in the present invention. The method of the present invention has been described through preferred embodiments, and relevant personnel can obviously make changes or appropriate changes and combinations to the methods and applications described herein without departing from the content, spirit and scope of the present invention to realize and apply this invention.
为更好地阐述本发明,下面通过实施例来说明。In order to illustrate the present invention better, the following examples illustrate.
实施例1:Example 1:
步骤一、将一只9周大的雄性C57BL/6小鼠用二氧化碳进行安乐死后将颈椎脱臼;采用70%浓度的乙醇溶液润湿小鼠腹部,用解剖剪切开小鼠腹腔至颅外生殖器,切割双侧腹部肌肉组织将切口延伸至肋骨,将十二指肠从幽门括约肌处切开,将小肠从腹腔内拉出后在回肠盲肠部将小肠切断;将收集好的小肠放入预冷的无钙、镁离子磷酸盐缓冲溶液中,置于冰上;用眼科镊清除小肠残留肠系膜,将小肠从十二指肠段沿纵轴纵向剖开,用预冷的无钙、镁离子磷酸盐缓冲溶液清洗去除肠道中的食糜,得到清洗干净的小肠;将清洗完毕的小肠分成三等分,分别剪取前端靠近胃部的4厘米小肠作为十二指肠段,中间段小肠的中间部4厘米为空肠段,后端靠近回盲肠部的4厘米为回肠段;图1是小肠分段收集示意图。其中1是幽门括约肌切断位置,2是回肠盲肠部切断位置,3是十二指肠段,4是空肠段,5是回肠段。Step 1. Euthanize a 9-week-old male C57BL/6 mouse with carbon dioxide and dislocate the cervical vertebrae; wet the abdomen of the mouse with 70% ethanol solution, and cut the abdominal cavity of the mouse to the extracranial genitalia by dissecting , cut the bilateral abdominal muscle tissue and extend the incision to the ribs, cut the duodenum from the pyloric sphincter, pull the small intestine out of the abdominal cavity and cut off the small intestine at the ileum and cecum; put the collected small intestine in pre-cooled Place it on ice in a phosphate buffer solution without calcium and magnesium ions; remove the residual mesentery of the small intestine with ophthalmic forceps, cut the small intestine longitudinally from the duodenum along the longitudinal axis, and use pre-cooled calcium and magnesium ion-free phosphate Wash with salt buffer solution to remove the chyme in the intestinal tract to obtain the cleaned small intestine; divide the cleaned small intestine into three equal parts, cut the 4 cm small intestine at the front end close to the stomach as the duodenum section, and the middle section of the small intestine in the middle The first 4 cm is the jejunum segment, and the 4 cm rear end close to the ileocecum is the ileum segment; Figure 1 is a schematic diagram of the collection of small intestine segments. Among them, 1 is the cutting position of the pyloric sphincter, 2 is the cutting position of the ileum and cecum, 3 is the duodenum segment, 4 is the jejunum segment, and 5 is the ileum segment.
将三段小肠部位用无水乙醇中浸泡5分钟后,用消毒盖玻片沿小肠绒毛面轻轻刮三段小肠部位3次;用预冷的无钙、镁离子磷酸盐缓冲溶液清洗三段小肠;用眼科剪将三段小肠沿纵轴剪成4毫米的小段,将十二指肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管1中清洗,将空肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管2中清洗,将回肠段放于含8毫升预冷的无钙、镁离子磷酸盐缓冲溶液的离心管3中清洗,清洗时分别将离心管1、2和3轻轻来回颠倒15次;清洗完毕后,将离心管1、2和3分别置于冰上使小肠碎片自然沉降于离心管1、2和3底部,然后去除上清液;分别在离心管1和2中加入8毫升预冷的浓度为2mM,pH为8.0的乙二胺四乙酸溶液后,横向埋于冰盒中用回旋式摇床以45rpm的速度振荡30分钟进行消化;在离心管3中加入8毫升预冷的浓度为5mM,pH为8.0的乙二胺四乙酸溶液后,横向埋于冰盒中用回旋式摇床以45rpm的速度振荡45分钟进行消化;将离心管1、2和3分别置于冰上自然沉降,去除上清液;向离心管1、2和3中分别加入预冷的无钙、镁离子磷酸盐缓冲溶液后,将离心管1、2和3分别上下颠倒15次进行清洗。After immersing the three sections of small intestine in absolute ethanol for 5 minutes, gently scrape the three sections of small intestine along the villi surface of the small intestine with a sterilized cover glass for 3 times; wash the three sections with pre-cooled calcium- and magnesium-ion-free phosphate buffer solution Small intestine: Use ophthalmic scissors to cut the three sections of small intestine into small sections of 4 mm along the longitudinal axis, put the duodenum section in centrifuge tube 1 containing 8 ml of pre-cooled calcium- and magnesium-ion-free phosphate buffer solution, and wash it. Clean the jejunum segment in centrifuge tube 2 containing 8 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and place the ileum segment in centrifuge tube 3 containing 8 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution During cleaning, gently invert centrifuge tubes 1, 2 and 3 back and forth 15 times; after cleaning, place centrifuge tubes 1, 2 and 3 on ice to allow small intestine fragments to settle naturally 3 bottom, and then remove the supernatant; add 8 ml of pre-cooled EDTA solution with a concentration of 2 mM and a pH of 8.0 to centrifuge tubes 1 and 2 respectively, bury them in an ice box horizontally and use a rotary shaker Shake at a speed of 45 rpm for 30 minutes for digestion; add 8 ml of pre-cooled EDTA solution with a concentration of 5 mM and a pH of 8.0 to the centrifuge tube 3, and bury it horizontally in an ice box with a rotary shaker at 45 rpm. Shake at a high speed for 45 minutes for digestion; place centrifuge tubes 1, 2 and 3 on ice to settle naturally, remove the supernatant; add pre-cooled calcium- and magnesium-free phosphate to centrifuge tubes 1, 2 and 3 respectively After buffering the solution, centrifuge tubes 1, 2 and 3 were washed by inverting up and down 15 times respectively.
步骤二,将步骤一中清洗完成的离心管1、2和3置于冰上自然沉降,去除上清液后,分别加入7.5毫升预冷的无钙、镁离子磷酸盐缓冲溶液,轻柔振荡50次,脱出小肠碎片中的隐窝,随后将离心管1、2和3置于冰上自然沉降后,将离心管1、2和3上清液合并收集至50毫升离心管4中;采用100微米孔径的细胞筛对离心管4中的上清液进行过滤,滤液转移至50毫升离心管5中;重复多次,直至每100微升离心管4中的收集液中少于10个隐窝时,停止收集。Step 2: Place the centrifuge tubes 1, 2 and 3 cleaned in step 1 on ice to settle naturally. After removing the supernatant, add 7.5 ml of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and shake gently for 50 The second time, the crypts in the small intestine fragments were removed, and then centrifuge tubes 1, 2 and 3 were placed on ice to settle naturally, and the supernatants of centrifuge tubes 1, 2 and 3 were combined and collected into 50 ml centrifuge tube 4; using 100 Filter the supernatant in the centrifuge tube 4 with a cell sieve with a micron pore size, and transfer the filtrate to the 50 ml centrifuge tube 5; repeat several times until there are less than 10 crypts in the collected liquid in the centrifuge tube 4 per 100 microliters , stop collecting.
步骤三、将步骤二中得到的含有隐窝的离心管5以150g转速和4℃温度下离心10分钟;去除离心管5中的上清液,加入3毫升预冷的无钙、镁离子磷酸盐缓冲溶液后,得隐窝悬液;将隐窝悬液转移到15毫升离心管6中以150g转速和4℃温度下离心10分钟,去除离心管6中的上清液,得隐窝沉淀,并将隐窝沉淀置于冰上。Step 3, centrifuge the centrifuge tube 5 containing crypts obtained in step 2 at a speed of 150g and a temperature of 4°C for 10 minutes; remove the supernatant in the centrifuge tube 5, and add 3 ml of precooled calcium- and magnesium-ion-free phosphoric acid After the salt buffer solution, the crypt suspension was obtained; the crypt suspension was transferred to a 15 ml centrifuge tube 6 and centrifuged at 150g and 4°C for 10 minutes, and the supernatant in the centrifuge tube 6 was removed to obtain the crypt precipitate , and place the crypt pellet on ice.
步骤四、向步骤三中得到的隐窝沉淀中按照每孔50微升的剂量加入相应体积的冰上预融化的复合凝胶液,用预冷移液枪头在冰上轻轻吹打形成均匀小肠隐窝复合凝胶悬液1;将小肠隐窝复合凝胶悬液1按照每孔50微升体积接种于37℃预热的24孔培养板1中;将24孔培养板1置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板1的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到初代小肠类器官;Step 4: Add a corresponding volume of pre-thawed composite gel solution on ice to the crypt pellet obtained in Step 3 at a dose of 50 microliters per well, and gently blow on ice with a pre-cooled pipette tip to form a uniform gel. Small intestinal crypt complex gel suspension 1; inoculate the small intestinal crypt complex gel suspension 1 in a 24-well culture plate 1 preheated at 37°C in a volume of 50 microliters per well; place the 24-well culture plate 1 at temperature In a carbon dioxide incubator at 37°C for 30 minutes; after the composite gel is completely polymerized, add 500 microliters of complete medium to each well of 24-well culture plate 1, and replace the complete medium every 3 days to obtain the primary small intestine organoids;
图2是小肠类器官体外培养第一天和第四天时的组织形态图。图2的A是原代分离十二指肠隐窝形态代表性图像,A1是十二指肠隐窝经过4天培养后形成类器官代表性图像;B是原代分离空肠隐窝形态代表性图像,B1是空肠隐窝经过4天培养后形成类器官代表性图像;C是原代分离回肠隐窝形态代表性图像,C1是回肠隐窝经过4天培养后形成类器官代表性图像。Figure 2 is the tissue morphology of the small intestinal organoids on the first day and the fourth day of in vitro culture. Figure 2 A is a representative image of the primary isolated duodenal crypt morphology, A1 is a representative image of the duodenal crypt formed after 4 days of culture; B is a representative image of the primary isolated jejunal crypt morphology Image, B1 is a representative image of organoids formed from jejunal crypts after 4 days of culture; C is a representative image of the morphology of primary isolated ileal crypts, and C1 is a representative image of organoids formed from ileal crypts after 4 days of culture.
从图2中可以看到,小肠类器官在体外具有稳定的组织生长性。It can be seen from Figure 2 that small intestinal organoids have stable tissue growth in vitro.
步骤五、在步骤四接种后6天,在步骤四中的24孔培养板1的每孔中加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液2;用注射器吸取全部复合凝胶悬液2后推出,重复一次,使隐窝类似结构从小肠类器官中释放,得到解离小肠类器官悬液1;将解离小肠类器官悬液1转移至15毫升离心管7中,以200g转速和4℃温度下离心10分钟,去除离心管7中上清液;向含有解离小肠类器官悬液1的离心管7中加入175微升冰上预融化的复合凝胶液,用移液枪吹打3-4次制成冰上预融化的复合凝胶悬液3;将复合凝胶悬液3按照每孔50微升体积接种于37℃预热24孔培养板2中;将24孔培养板2置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板2的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到一次传代小肠类器官。Step 5: 6 days after inoculation in step 4, add 500 microliters of pre-cooled calcium- and magnesium-ion-free phosphate buffered saline buffer solution to each well of the 24-well culture plate 1 in step 4 and place it on ice. The composite gel in each hole was blown repeatedly with a gun until it was broken to obtain a composite gel suspension 2; the entire composite gel suspension 2 was sucked up with a syringe and pushed out, and repeated once to release the crypt-like structure from the small intestine organoid to obtain Dissociate the small intestinal organoid suspension 1; transfer the dissociated small intestinal organoid suspension 1 to a 15 ml centrifuge tube 7, centrifuge at a speed of 200g and a temperature of 4°C for 10 minutes, remove the supernatant in the centrifuge tube 7; Add 175 microliters of pre-thawed composite gel solution on ice to the centrifuge tube 7 of the dissociated small intestinal organoid suspension 1, and pipette 3-4 times with a pipette gun to prepare the pre-thawed composite gel suspension 3 on ice; Inoculate the composite gel suspension 3 into a preheated 24-well culture plate 2 at 37°C according to a volume of 50 microliters per well; place the 24-well culture plate 2 in a carbon dioxide incubator at a temperature of 37°C for 30 minutes; After the gel was completely polymerized, 500 microliters of complete medium was added to each well of the 24-well culture plate 2, and the complete medium was replaced every 3 days to obtain a passage small intestinal organoid.
步骤六、重复步骤五的步骤11次,可以得到传代十三次的小肠类器官,图3是传代12次的小肠类器官体外培养第一天和第四天时的组织形态图。Step 6. Repeat step 5 for 11 times to obtain small intestinal organoids with 13 passages. Figure 3 is the histological diagram of the small intestinal organoids with 12 passages on the first day and the fourth day of in vitro culture.
图3的D是传代12代后十二指肠类器官解离后隐窝类似结构代表性图像,D1是传代培养4天后类器官代表性图像;E是传代12代后空肠类器官解离后隐窝类似结构代表性图像,D1是传代培养4天后类器官代表性图像;F是传代12代后回肠类器官解离后隐窝类似结构代表性图像,D1是传代培养4天后类器官代表性图像。Figure 3D is a representative image of similar structures of crypts after dissociation of duodenal organoids after 12 passages, D1 is a representative image of organoids after 4 days of subculture; E is the dissociation of jejunum organoids after 12 passages Representative images of similar structures of crypts, D1 is a representative image of organoids after 4 days of subculture; F is a representative image of similar structures of crypts after dissociation of ileal organoids after passage 12, D1 is a representative image of organoids after 4 days of subculture image.
从图3中可以看到,小肠类器官在体外传代12次之后,仍然能够具有稳定的组织生长性。It can be seen from Figure 3 that the small intestinal organoids can still have stable tissue growth after 12 passages in vitro.
步骤七、在步骤五小肠类器官传代3天后,将24孔培养板2中的传代小肠类器官去除培养基后,加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液3;将复合凝胶悬液3转移至15毫升离心管8中,以200g转速和4℃温度下离心10分钟,去除离心管8中上清液;在离心管8中加入1毫升冻存液后,得小肠类器官重悬液;以2孔小肠类器官重悬液为一组,转移至一根2毫升冻存管中,放于含异丙醇的冻存盒中,-80℃放置24小时后放入液氮中长期保存,得到冻存小肠类器官。Step 7. After 3 days of passage of small intestinal organoids in step 5, remove the medium from the passaged small intestinal organoids in 24-well culture plate 2, add 500 microliters of pre-cooled calcium and magnesium ion-free phosphate buffer solution, and place on ice above, use a pipette gun to repeatedly blow the composite gel in each well until it breaks to obtain a composite gel suspension 3; Centrifuge for 10 minutes, remove the supernatant in centrifuge tube 8; add 1 ml of cryopreservation solution to centrifuge tube 8 to obtain small intestinal organoid resuspension; use 2-well small intestinal organoid resuspension as a group, transfer to a Put them in a 2ml cryopreservation tube, put them in a cryopreservation box containing isopropanol, store them at -80°C for 24 hours, and then put them in liquid nitrogen for long-term storage to obtain cryopreserved small intestinal organoids.
步骤八、将步骤七种存有小肠类器官重悬液的冻存管从液氮中取出,立即放入37℃水浴锅中速溶,待小肠类器官重悬液完全融化后,转移小肠类器官重悬液到15毫升离心管9中,加入预冷基础培养基至5毫升,在转速200g条件下离心10分钟;去除离心管9的上清液后,加入100微升复合凝胶液,得到小肠类器官复苏重悬液;将小肠类器官复苏重悬液按照每孔50微升体积接种于37℃预热24孔培养板3中;将24孔培养板3置于温度为37℃的二氧化碳培养箱中30分钟;待复合凝胶完全聚合后,再向24孔培养板3的每孔中加入500微升完全培养基,每3天更换一次完全培养基,得到复苏小肠类器官。Step 8. Take out the cryopreservation tube containing the small intestinal organoid resuspension in step 7 from the liquid nitrogen, and immediately put it in a 37°C water bath for instant dissolution. After the small intestinal organoid resuspension is completely melted, transfer the small intestinal organoid Resuspend the liquid into a 15 ml centrifuge tube 9, add pre-cooled basal medium to 5 ml, and centrifuge at a speed of 200 g for 10 minutes; after removing the supernatant of the centrifuge tube 9, add 100 microliters of composite gel solution to obtain Resuspension of small intestinal organoid resuscitation; inoculate the resuspension of small intestinal organoid resuscitation into a preheated 24-well culture plate 3 at 37°C in a volume of 50 μl per well; place the 24-well culture plate 3 in carbon dioxide at a temperature of 37°C 30 minutes in the incubator; after the composite gel was completely polymerized, 500 microliters of complete medium was added to each well of 24-well culture plate 3, and the complete medium was replaced every 3 days to obtain resuscitated small intestinal organoids.
步骤九、以步骤四的初代小肠类器官作为鉴定对象,以标记肠道上皮细胞标志蛋白钙粘蛋白(E-cadherin)、吸收细胞标志蛋白绒毛蛋白(Villin)、潘氏细胞标志蛋白溶菌酶(Lysozyme)、杯状细胞标志蛋白粘蛋白(Mucin2)、内分泌细胞标志蛋白嗜铬粒蛋白(Chromogranin A)和L型细胞标志蛋白胰高血糖素样肽(GLP-1)蛋白为标记蛋白,培养6天后去除培养基,加入500微升预冷的无钙、镁离子磷酸盐缓冲溶液后置于冰上,用移液枪反复吹打每个孔的复合凝胶至破碎,得到复合凝胶悬液4;将复合凝胶悬液4转移至15毫升离心管10中,在转速200g条件下离心10分钟;去除离心管9的上清液后,加入提前冰上预冷的溶度为4%的多聚甲醛,在温度20℃条件下固定15分钟;固定完毕后,将离心管10中在转速200g条件下离心10分钟,去除上清液;在离心管10中加入无钙、镁离子磷酸盐缓冲溶液,在转速200g条件下离心5分钟后去除上清液,重复3次;随后向离心管10中的沉淀中加入溶度1毫升溶度为0.01%的亚甲基蓝溶液,在温度20℃条件下孵育20分钟;孵育完成后,将离心管10中在转速200g条件下离心10分钟,去除上清液;在离心管10中加入无钙、镁离子磷酸盐缓冲溶液,在转速200g条件下离心5分钟后去除上清液,重复3次;随后向离心管10中的沉淀中加入1毫升溶度为20%的蔗糖溶液,在温度4℃条件下过夜放置12小时,得到含有小肠类器官蔗糖溶液的离心管10。Step 9: Using the first-generation small intestinal organoids from Step 4 as the identification object to label the intestinal epithelial cell marker protein E-cadherin, the absorption cell marker protein villin (Villin), and the Paneth cell marker protein lysozyme ( Lysozyme), goblet cell marker protein mucin (Mucin2), endocrine cell marker protein chromogranin A (Chromogranin A) and L-type cell marker protein glucagon-like peptide (GLP-1) protein as marker proteins, cultured for 6 One day later, remove the medium, add 500 microliters of pre-cooled calcium- and magnesium-ion-free phosphate buffer solution, place it on ice, and repeatedly blow the composite gel in each well with a pipette until it breaks to obtain a composite gel suspension 4 ; Transfer the composite gel suspension 4 to a 15 ml centrifuge tube 10, and centrifuge at a speed of 200g for 10 minutes; after removing the supernatant of the centrifuge tube 9, add polyol with a solubility of 4% pre-cooled on ice in advance Polyoxymethylene, fixed at a temperature of 20°C for 15 minutes; after the fixation, centrifuge the centrifuge tube 10 at a speed of 200g for 10 minutes to remove the supernatant; add calcium and magnesium ion-free phosphate buffer solution, centrifuge at 200g for 5 minutes, remove the supernatant, and repeat 3 times; then add 1 ml of methylene blue solution with a solubility of 0.01% to the precipitate in the centrifuge tube 10, and incubate at a temperature of 20°C 20 minutes; after the incubation is completed, centrifuge the centrifuge tube 10 at a speed of 200g for 10 minutes to remove the supernatant; add calcium and magnesium ion-free phosphate buffer solution to the centrifuge tube 10, and centrifuge at a speed of 200g for 5 minutes Finally, remove the supernatant, and repeat 3 times; then add 1 ml of sucrose solution with a solubility of 20% to the precipitate in the centrifuge tube 10, and place it overnight at a temperature of 4° C. for 12 hours to obtain a sucrose solution containing small intestinal organoids. Centrifuge tube 10.
步骤十、将离心管10中的小肠类器官蔗糖溶液转移至1.5毫升离心管11中,在转速4000rpm条件下离心45秒后加入50-100微升冰冻切片包埋剂,轻轻悬浮后,在温度20℃条件下静止25分钟;待小肠类器官沉降于1.5毫升离心管11后,用干冰速冻2分钟;将成块小肠类器官从离心管11中取出,含小肠类器官的那一面向下,置于含冰冻切片包埋剂的包埋盒中二次包埋,用干冰速冻30秒,得到小肠类器官包埋物;速冻完成后,采用冰冻切片机对小肠类器官包埋物以9微米的厚度进行切片,得小肠类器官包埋切片1;将小肠类器官包埋切片1置于烘片机上,在42℃温度下烘30分钟后,制得烘干后的小肠类器官包埋切片2,将小肠类器官包埋切片2放入切片盒中,在-80℃冰箱中保存备用。Step 10. Transfer the small intestinal organoid sucrose solution in the centrifuge tube 10 to a 1.5 ml centrifuge tube 11, centrifuge at 4000 rpm for 45 seconds, add 50-100 microliters of cryosection embedding agent, suspend gently, and place in Stand still for 25 minutes at a temperature of 20°C; after the small intestinal organoids settle in the 1.5 ml centrifuge tube 11, freeze them with dry ice for 2 minutes; take out the block of small intestinal organoids from the centrifuge tube 11, with the side containing the small intestinal organoids facing down, Embedded for the second time in an embedding box containing frozen section embedding agent, and quick-frozen with dry ice for 30 seconds to obtain the small intestinal organoid embedding; The thickness of the small intestine organoid embedding slice 1 was obtained; the small intestinal organoid embedding slice 1 was placed on a drying machine, and after drying at 42°C for 30 minutes, the dried small intestinal organoid embedding slice was obtained 2. Put the small intestinal organoid-embedded slice 2 into a slice box and store it in a -80°C refrigerator for later use.
步骤十一、将步骤十中得到的小肠类器官包埋切片2从-80℃冰箱取出,置于烘片机上,在42℃温度下烘20分钟;随后,将小肠类器官包埋切片2放于孵育盒中,用磷酸盐缓冲溶液清洗10分钟;随后,去除磷酸盐缓冲溶液,加入抗原封闭液,温度20℃条件下孵育40分钟,得小肠类器官包埋切片3;在小肠类器官包埋切片3中加入一抗,在温度4℃条件下过夜放置12小时,得小肠类器官包埋切片4。Step 11. Take the small intestinal organoid-embedded slice 2 obtained in step 10 out of the -80°C refrigerator, place it on a drying machine, and bake it at 42°C for 20 minutes; then, place the small intestinal organoid-embedded slice 2 In the incubation box, wash with phosphate buffer solution for 10 minutes; then, remove the phosphate buffer solution, add antigen blocking solution, and incubate at 20°C for 40 minutes to obtain small intestinal organoid embedded slice 3; The primary antibody was added to the embedded slice 3, and left overnight at 4°C for 12 hours to obtain the small intestinal organoid embedded slice 4.
步骤十二、将步骤十一中得到的小肠类器官包埋切片4用磷酸盐缓冲溶液重复清洗3次,每次5分钟,得小肠类器官包埋切片5;在小肠类器官包埋切片5中加入与步骤十一中一抗相对应的二抗,温度20℃条件下孵育30分钟,得小肠类器官包埋切片6;将小肠类器官包埋切片6用磷酸盐缓冲溶液重复清洗4次,每次5分钟;随后,加入2-(4-脒基苯基)-6-吲哚脒二盐酸盐溶液,温度20℃条件下孵育5分钟;用超纯水以清洗2次,每次5分钟,得小肠类器官包埋切片7;最后用封片剂对小肠类器官包埋切片7进行封片,得到小肠类器官封片。Step 12. Wash the small intestinal organoid-embedded slice 4 obtained in step 11 repeatedly with phosphate buffered saline solution for 3 times, each time for 5 minutes, to obtain the small intestinal organoid-embedded slice 5; Add the secondary antibody corresponding to the primary antibody in step 11, and incubate at 20°C for 30 minutes to obtain the small intestinal organoid-embedded slice 6; wash the small intestinal organoid-embedded slice 6 with phosphate buffer solution repeatedly 4 times , 5 minutes each time; then, add 2-(4-amidinophenyl)-6-indoleamidine dihydrochloride solution and incubate at 20°C for 5 minutes; wash with ultrapure water twice, each After 5 minutes, the small intestinal organoid-embedded section 7 was obtained; finally, the small intestinal organoid-embedded section 7 was mounted with a mounting agent to obtain the small intestinal organoid-embedded section.
步骤十三,采用激光共聚焦显微镜对步骤十二中得到的小肠类器官封片进行观察,获取免疫荧光图像及鉴定。In step 13, the small intestinal organoid obtained in step 12 is observed with a laser confocal microscope, and immunofluorescence images are obtained and identified.
图4是小肠类器官的鉴定结果图。Figure 4 is a diagram of the identification results of small intestinal organoids.
图4的G、H、I、P、Q、R分别是肠道上皮细胞标志蛋白钙粘蛋白(E-cadherin)、吸收细胞标志蛋白绒毛蛋白(Villin)、潘氏细胞标志蛋白溶菌酶(Lysozyme)、杯状细胞标志蛋白粘蛋白(Mucin2)、内分泌细胞标志蛋白嗜铬粒蛋白(Chromogranin A)和L型细胞标志蛋白胰高血糖素样肽(GLP-1)标记的肠道不同类型细胞在十二指肠类器官中表达的免疫荧光代表性图像;G0、H0、I0、P0、Q0、R0分别是上述标志蛋白标记的不同类型肠道细胞在小鼠十二指肠组织中表达的免疫荧光代表性图像;G, H, I, P, Q, and R in Figure 4 are intestinal epithelial cell marker protein cadherin (E-cadherin), absorption cell marker protein villin (Villin), Paneth cell marker protein lysozyme (Lysozyme), respectively. ), goblet cell marker protein Mucin (Mucin2), endocrine cell marker protein Chromogranin A (Chromogranin A) and L-type cell marker protein glucagon-like peptide (GLP-1) marked different types of intestinal cells in Representative images of immunofluorescence expression in duodenal organoids; G0, H0, I0, P0, Q0, R0 are the immunofluorescence expression of different types of intestinal cells marked by the above marker proteins in mouse duodenal tissue Fluorescent representative images;
图4的J、K、L、S、T、U分别是肠道上皮细胞标志蛋白钙粘蛋白(E-cadherin)、吸收细胞标志蛋白绒毛蛋白(Villin)、潘氏细胞标志蛋白溶菌酶(Lysozyme)、杯状细胞标志蛋白粘蛋白(Mucin2)、内分泌细胞标志蛋白嗜铬粒蛋白(Chromogranin A)和L型细胞标志蛋白胰高血糖素样肽(GLP-1)标记的肠道不同类型细胞在空肠类器官中表达的免疫荧光代表性图像;J0、K0、L0、S0、T0、U0分别是上述标志蛋白标记的不同类型肠道细胞在小鼠空肠组织中表达的免疫荧光代表性图像。J, K, L, S, T, and U in Figure 4 are the intestinal epithelial cell marker protein E-cadherin (E-cadherin), the absorption cell marker protein villin (Villin), the Paneth cell marker protein lysozyme (Lysozyme ), goblet cell marker protein Mucin (Mucin2), endocrine cell marker protein Chromogranin A (Chromogranin A) and L-type cell marker protein glucagon-like peptide (GLP-1) marked different types of intestinal cells in Representative immunofluorescence images expressed in jejunal organoids; J0, K0, L0, S0, T0, and U0 are representative immunofluorescence images expressed in mouse jejunum tissues by different types of intestinal cells labeled with the above marker proteins.
图4的M、N、O、V、W、X分别是肠道上皮细胞标志蛋白钙粘蛋白(E-cadherin)、吸收细胞标志蛋白绒毛蛋白(Villin)、潘氏细胞标志蛋白溶菌酶(Lysozyme)、杯状细胞标志蛋白粘蛋白(Mucin2)、内分泌细胞标志蛋白嗜铬粒蛋白(Chromogranin A)和L型细胞标志蛋白胰高血糖素样肽(GLP-1)标记的肠道不同类型细胞在回肠类器官中表达的免疫荧光代表性图像;M0、N0、O0、V0、W0、X0分别是上述标志蛋白标记的不同类型肠道细胞在小鼠空肠组织中表达的免疫荧光代表性图像。M, N, O, V, W, and X in Figure 4 are intestinal epithelial cell marker protein cadherin (E-cadherin), absorption cell marker protein villin (Villin), Paneth cell marker protein lysozyme (Lysozyme), respectively. ), goblet cell marker protein Mucin (Mucin2), endocrine cell marker protein Chromogranin A (Chromogranin A) and L-type cell marker protein glucagon-like peptide (GLP-1) marked different types of intestinal cells in Representative immunofluorescence images expressed in ileal organoids; M0, N0, O0, V0, W0, and X0 are representative immunofluorescence images of expression of different types of intestinal cells labeled with the above marker proteins in mouse jejunum tissue.
从图4中可以看到,与小鼠体内小肠绒毛相同,体外小肠类器官也由单层上皮细胞组成;而且与体内小肠绒毛中细胞组成结构相同,分化多种不同类型肠道上皮细胞,包括肠道吸收细胞、潘氏细胞、杯状细胞、内分泌细胞和L型细胞。It can be seen from Figure 4 that, the same as the small intestinal villi in mice, the small intestinal organoids in vitro are also composed of a single layer of epithelial cells; and the cell composition and structure are the same as those in the small intestinal villi in vivo, and differentiate a variety of different types of intestinal epithelial cells, including Intestinal absorptive cells, Paneth cells, goblet cells, endocrine cells and L-type cells.
因此,从上述步骤和结果可以看出,本发明提供的基于小鼠不同区段小肠的体外类器官3D培养、传代、冻存、复苏和鉴定方法是稳定,可靠,有效的。Therefore, it can be seen from the above steps and results that the methods for in vitro organoid 3D culture, passage, cryopreservation, recovery and identification based on different sections of the small intestine of mice provided by the present invention are stable, reliable and effective.
以上所述仅是本发明的特定实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。The above is only a specific embodiment of the present invention, and it should be pointed out that for those of ordinary skill in the art, without departing from the principle of the present invention, some improvements and modifications can also be made. It should be regarded as the protection scope of the present invention.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810311126.9A CN108728399A (en) | 2018-04-09 | 2018-04-09 | External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810311126.9A CN108728399A (en) | 2018-04-09 | 2018-04-09 | External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108728399A true CN108728399A (en) | 2018-11-02 |
Family
ID=63941311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810311126.9A Pending CN108728399A (en) | 2018-04-09 | 2018-04-09 | External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108728399A (en) |
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109679893A (en) * | 2019-01-17 | 2019-04-26 | 浙江工商大学 | Enteric epithelium monolayer cultivation and characterizing method based on mouse intestinal stem cell |
| CN109880878A (en) * | 2019-01-17 | 2019-06-14 | 浙江工商大学 | A rapid method for evaluating the effects of food functional components on intestinal growth characteristics based on mouse intestinal organoids |
| CN110373378A (en) * | 2019-07-12 | 2019-10-25 | 浙江工商大学 | It is a kind of based on the external gastrointestinal model and its construction method of primary intestinal cell and application |
| CN111849865A (en) * | 2020-07-01 | 2020-10-30 | 浙江理工大学 | A method for culturing small intestinal organoids in a 3D porous polylactic acid matrix |
| CN112067382A (en) * | 2020-08-07 | 2020-12-11 | 佛山科学技术学院 | A kind of preparation method of small intestine slice |
| CN112111445A (en) * | 2020-09-16 | 2020-12-22 | 浙江工商大学 | In-vitro monolayer culture and characterization method for constructing mouse intestinal epithelium by using Transwell |
| CN112266898A (en) * | 2020-11-03 | 2021-01-26 | 华南理工大学 | Culture method and culture medium for colorectal cancer organoids |
| CN112375730A (en) * | 2020-11-23 | 2021-02-19 | 创芯国际生物科技(广州)有限公司 | Small intestine tissue digestion composition, digestive juice system and application thereof |
| CN112501111A (en) * | 2020-12-16 | 2021-03-16 | 中国科学院亚热带农业生态研究所 | Molecular culture medium for culturing porcine small intestine organoid |
| CN113106066A (en) * | 2021-05-13 | 2021-07-13 | 杭州艾名医学科技有限公司 | Sarcoma cell culture medium and method for producing Matrigel stock solution in vitro by using culture medium |
| CN114058588A (en) * | 2021-11-12 | 2022-02-18 | 复旦大学附属中山医院 | Preparation method of human-derived intestinal adenoma organoid |
| CN114107208A (en) * | 2021-11-12 | 2022-03-01 | 复旦大学附属中山医院 | A kind of preparation method of human-derived organoid bank |
| CN114480274A (en) * | 2021-12-30 | 2022-05-13 | 中国人民解放军海军军医大学第一附属医院 | Method for directionally differentiating Pan cells in intestinal organoid |
| CN114480285A (en) * | 2021-11-30 | 2022-05-13 | 西安交通大学医学院第一附属医院 | Recovery liquid, culture liquid and recovery culture method for glioma organoid |
| CN116496980A (en) * | 2023-06-28 | 2023-07-28 | 北京嘉士腾医学检验实验室有限公司 | Intestinal crypt separating liquid for inflammatory bowel disease, separating method and in-vitro 3D organoid culture method |
| CN120738105A (en) * | 2025-08-27 | 2025-10-03 | 澳优乳业(中国)有限公司 | Intestinal organoid model and culture method and application thereof |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101371853A (en) * | 2007-08-22 | 2009-02-25 | 何东南 | Use of small intestine SP cells in preparing medicament for treating damage of intestines |
| WO2014153294A1 (en) * | 2013-03-17 | 2014-09-25 | The Regents Of The University Of California | Method to expand and transduce cultured human small and large intestinal stem cells |
| WO2016061464A1 (en) * | 2014-10-17 | 2016-04-21 | Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center | In vivo model of human small intetine using pluripotent stem cells and methods of making and using same |
| WO2017036533A1 (en) * | 2015-09-03 | 2017-03-09 | Ecole Polytechnique Federale De Lausanne (Epfl) | Three-dimensional hydrogels for culturing adult epithelial stem cells and organoids |
| KR20180023640A (en) * | 2016-08-26 | 2018-03-07 | 한국원자력의학원 | Method for efficient long-term cryopreservation of intestine organoid by a combination of organoid state and optimal treatment timing of Rho-kinase inhibitor |
| WO2018052953A1 (en) * | 2016-09-13 | 2018-03-22 | President And Fellows Of Harvard College | Methods relating to intestinal organ-on-a-chip |
| CN108085296A (en) * | 2018-01-29 | 2018-05-29 | 清华大学 | Culture medium and application thereof |
-
2018
- 2018-04-09 CN CN201810311126.9A patent/CN108728399A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101371853A (en) * | 2007-08-22 | 2009-02-25 | 何东南 | Use of small intestine SP cells in preparing medicament for treating damage of intestines |
| WO2014153294A1 (en) * | 2013-03-17 | 2014-09-25 | The Regents Of The University Of California | Method to expand and transduce cultured human small and large intestinal stem cells |
| WO2016061464A1 (en) * | 2014-10-17 | 2016-04-21 | Children's Hospital Center, D/B/A Cincinnati Children's Hospital Medical Center | In vivo model of human small intetine using pluripotent stem cells and methods of making and using same |
| WO2017036533A1 (en) * | 2015-09-03 | 2017-03-09 | Ecole Polytechnique Federale De Lausanne (Epfl) | Three-dimensional hydrogels for culturing adult epithelial stem cells and organoids |
| KR20180023640A (en) * | 2016-08-26 | 2018-03-07 | 한국원자력의학원 | Method for efficient long-term cryopreservation of intestine organoid by a combination of organoid state and optimal treatment timing of Rho-kinase inhibitor |
| WO2018052953A1 (en) * | 2016-09-13 | 2018-03-22 | President And Fellows Of Harvard College | Methods relating to intestinal organ-on-a-chip |
| CN108085296A (en) * | 2018-01-29 | 2018-05-29 | 清华大学 | Culture medium and application thereof |
Non-Patent Citations (8)
| Title |
|---|
| ISABELLA DOTTI等: "Alterations in the epithelial stem cell compartment could contribute to permanent changes in the mucosa of patients with ulcerative colitis", 《GUT》 * |
| NOBEN, MANUEL等: "Human intestinal epithelium in a dish: Current models for research into gastrointestinal pathophysiology", 《UNITED EUROPEAN GASTROENTEROLOGY JOURNAL》 * |
| 万光升等: "小鼠小肠类器官体外培养体系的建立与应用", 《中国实验动物学报》 * |
| 周莹等: "大鼠小肠上皮类器官单位的分离培养鉴定", 《组织工程与重建外科杂志》 * |
| 宋东娟等: "小肠类器官培养技术的建立和优化", 《胃肠病学》 * |
| 曾玉晓: "二维和三维诱导的人胚胎干细胞来源RPE细胞的生物学特性比较研究", 《中国优秀硕士学位论文全文数据库(电子期刊)医药卫生科技辑》 * |
| 楼俪泓等: "脱氧胆酸对C57BL/6小鼠回肠类器官生长的影响", 《南方医科大学学报》 * |
| 高云等: "肠类器官的研究与应用", 《国际消化病杂志》 * |
Cited By (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109679893A (en) * | 2019-01-17 | 2019-04-26 | 浙江工商大学 | Enteric epithelium monolayer cultivation and characterizing method based on mouse intestinal stem cell |
| CN109880878A (en) * | 2019-01-17 | 2019-06-14 | 浙江工商大学 | A rapid method for evaluating the effects of food functional components on intestinal growth characteristics based on mouse intestinal organoids |
| CN110373378A (en) * | 2019-07-12 | 2019-10-25 | 浙江工商大学 | It is a kind of based on the external gastrointestinal model and its construction method of primary intestinal cell and application |
| CN111849865A (en) * | 2020-07-01 | 2020-10-30 | 浙江理工大学 | A method for culturing small intestinal organoids in a 3D porous polylactic acid matrix |
| CN112067382A (en) * | 2020-08-07 | 2020-12-11 | 佛山科学技术学院 | A kind of preparation method of small intestine slice |
| CN112111445A (en) * | 2020-09-16 | 2020-12-22 | 浙江工商大学 | In-vitro monolayer culture and characterization method for constructing mouse intestinal epithelium by using Transwell |
| CN112266898A (en) * | 2020-11-03 | 2021-01-26 | 华南理工大学 | Culture method and culture medium for colorectal cancer organoids |
| CN112375730A (en) * | 2020-11-23 | 2021-02-19 | 创芯国际生物科技(广州)有限公司 | Small intestine tissue digestion composition, digestive juice system and application thereof |
| CN112501111A (en) * | 2020-12-16 | 2021-03-16 | 中国科学院亚热带农业生态研究所 | Molecular culture medium for culturing porcine small intestine organoid |
| CN113106066A (en) * | 2021-05-13 | 2021-07-13 | 杭州艾名医学科技有限公司 | Sarcoma cell culture medium and method for producing Matrigel stock solution in vitro by using culture medium |
| CN113106066B (en) * | 2021-05-13 | 2022-08-23 | 杭州艾名医学科技有限公司 | Sarcoma cell culture medium and method for producing Matrigel stock solution in vitro by using culture medium |
| CN114058588A (en) * | 2021-11-12 | 2022-02-18 | 复旦大学附属中山医院 | Preparation method of human-derived intestinal adenoma organoid |
| CN114107208A (en) * | 2021-11-12 | 2022-03-01 | 复旦大学附属中山医院 | A kind of preparation method of human-derived organoid bank |
| CN114480285A (en) * | 2021-11-30 | 2022-05-13 | 西安交通大学医学院第一附属医院 | Recovery liquid, culture liquid and recovery culture method for glioma organoid |
| CN114480274A (en) * | 2021-12-30 | 2022-05-13 | 中国人民解放军海军军医大学第一附属医院 | Method for directionally differentiating Pan cells in intestinal organoid |
| CN116496980A (en) * | 2023-06-28 | 2023-07-28 | 北京嘉士腾医学检验实验室有限公司 | Intestinal crypt separating liquid for inflammatory bowel disease, separating method and in-vitro 3D organoid culture method |
| CN120738105A (en) * | 2025-08-27 | 2025-10-03 | 澳优乳业(中国)有限公司 | Intestinal organoid model and culture method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108728399A (en) | External organoid 3D based on mouse difference section small intestine is cultivated, passed on, freezing, recovering and identification method | |
| Okumura et al. | ROCK inhibitor converts corneal endothelial cells into a phenotype capable of regenerating in vivo endothelial tissue | |
| KR101994492B1 (en) | Method of producing retinal pigment epithelial cell sheet | |
| PT1594957E (en) | Progenitor cells from wharton`s jelly of human umbilical cord | |
| ES2653679T3 (en) | Dermal fibroblasts for the treatment of degenerative disc disease | |
| CN105586309B (en) | A method of obtaining safe and effective umbilical cord mesenchymal stem cells | |
| CA2542133A1 (en) | Human corneal endothelial cells and methods of obtaining and culturing cells for corneal cell transplantation | |
| RU2160112C1 (en) | Method for producing cellular transplant from fetus tissues | |
| CN107996559B (en) | A kind of neural stem cell cryopreservation solution and using method thereof | |
| CN108103013A (en) | The enzyme digestion original cuiture and identification method of a kind of gastric and esophageal engaging portion smooth muscle cell | |
| CN113056556A (en) | Compositions and methods for preserving or culturing ocular cells | |
| CN101748095B (en) | Method for directionally inducing cartilage cells | |
| CN110050780A (en) | Frozen stock solution and its application in umbilical cord mesenchymal stem cells freeze | |
| Selwood et al. | Cleavage in vivo and in culture in the dasyurid marsupial Antechinus stuartii (Macleay) | |
| Lukovac et al. | Intestinal crypt organoids as experimental models | |
| CN108739795A (en) | A kind of fat stem cell frozen stock solution and its cryopreservation methods | |
| RU2323252C1 (en) | Method for culturing human mesenchymal stem cells ex vivo | |
| CN109679893A (en) | Enteric epithelium monolayer cultivation and characterizing method based on mouse intestinal stem cell | |
| CN103013910A (en) | Human degenerative intervertebral disc cartilage endplate stem cell, preparation method and application thereof | |
| Dale et al. | Rock Inhibitor Y‐27632 Enables Feeder‐Free, Unlimited Expansion of Sus scrofa domesticus Swine Airway Stem Cells to Facilitate Respiratory Research | |
| WO2012085298A1 (en) | Fibrin gel containing sclerocorneal limbus cells and the use thereof in ocular surface bioengineering | |
| CN117625535B (en) | An in vitro method for culturing a brain-like model | |
| Moskovtsev et al. | Methods to Select Ejaculated, Epididymal, and Testicular Spermatozoa for Assisted Conception | |
| CN120290472B (en) | Menstrual blood organoid and application thereof | |
| 장재영 | Establishment of Small Intestine Organoid Culture Model in C57BL/6 Mice and Its Benefits over Tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20181102 |